Skip to main content
Top
Published in: Drug Safety 5/2012

01-05-2012 | Short Communication

Promoting Spontaneous Adverse Drug Reaction Reporting in Hospitals Using a Hyperlink to the Online Reporting Form

An Ecological Study in Portugal

Authors: Dr Inês Ribeiro-Vaz, Cristina Santos, Altamiro da Costa-Pereira, Ricardo Cruz-Correia

Published in: Drug Safety | Issue 5/2012

Login to get access

Abstract

Background: Spontaneous adverse drug reaction (ADR) reporting has been described as an efficient method to detect drug safety signals. However, under-reporting is a major issue undermining the effectiveness of spontaneous reports. Among hospitalized patients, ADRs are a particularly serious problem because these patients are often treated with more than one drug, and these drugs are often new and aggressive.
Objective: To promote spontaneous ADR reporting by healthcare professionals working in hospitals in the northern regions of Portugal, we propose the inclusion of a hyperlink to an online ADR reporting form on hospitals’ electronic patient records (EPRs). The main aim of this study was to evaluate the impact of these hyperlinks on the number of spontaneous ADR reports to the Northern Pharmacovigilance Centre (UFN — Unidade de Farm-acovigilância do Norte). We also assess the number of daily UFN website visits before and after the inclusion of the hyperlinks.
Methods: An ecological study was performed in northern Portuguese hospitals from 2006 to 2010. The hyperlinks were included in either EPRs or on computer desktops. The median of spontaneous ADR reports (total and online) per month and the respective ranges were presented before and after the intervention in all hospitals in this study. The comparisons were performed using the Mann-Whitney U-test.
Results: Sixteen hospital centres were involved in the study (27 hospitals). Eleven centres (18 hospitals) included the hyperlinks. Considering the hospitals with hyperlink access to the EPRs, the median ADR reports per month significantly increased, from two (range 0–12) to five reports (range 1–17). The median of ADR reports per month using the online form also increased significantly, from one (range 0–5) before the intervention to four (range 1–17) after it. Moreover, serious ADRs increased 3-fold, and non-previously described ADRs increased 4.5-fold. None of these significant increases were observed in the hospitals where the hyperlink was not installed. We also found a significant increase in daily UFN website visits, from ten before the intervention to 27 after it (p<0.001).
Conclusion: The increase in ADR reporting shows that the inclusion of hyperlinks to online ADR reporting forms is an easy and cost-effective way to change health professional behaviours with regard to spontaneous ADR reports.
Literature
1.
go back to reference Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA 1998; 279(15): 1200–5PubMedCrossRef Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA 1998; 279(15): 1200–5PubMedCrossRef
2.
go back to reference Lasser KE, Allen PD, Woolhandler, et al. Timing of new black box warnings and withdrawals for prescription medications. JAMA 2002; 287(17): 2215–20PubMedCrossRef Lasser KE, Allen PD, Woolhandler, et al. Timing of new black box warnings and withdrawals for prescription medications. JAMA 2002; 287(17): 2215–20PubMedCrossRef
5.
go back to reference Walker R, Edwards C. Clinical pharmacy and therapeutics. 3rd ed. Edinburgh: Churchill Livingstone, 2003 Walker R, Edwards C. Clinical pharmacy and therapeutics. 3rd ed. Edinburgh: Churchill Livingstone, 2003
6.
go back to reference McGettigan P, Golden J, Conroy RM, et al. Reporting of adverse drug reactions by hospital doctors and the response to intervention. Br J Clin Pharmacol 1997; 44(1): 98–100PubMedCrossRef McGettigan P, Golden J, Conroy RM, et al. Reporting of adverse drug reactions by hospital doctors and the response to intervention. Br J Clin Pharmacol 1997; 44(1): 98–100PubMedCrossRef
7.
go back to reference Smith CC, Bennett PM, Pearce HM, et al. Adverse drug reactions in a hospital general medical unit meriting notification to the Committee on Safety of Medicines. Br J Clin Pharmacol 1996; 42(4): 423–9PubMedCrossRef Smith CC, Bennett PM, Pearce HM, et al. Adverse drug reactions in a hospital general medical unit meriting notification to the Committee on Safety of Medicines. Br J Clin Pharmacol 1996; 42(4): 423–9PubMedCrossRef
8.
go back to reference Farmacovigilância em Portugal. 2004, Lisboa: INFARMED-Instituto Nacional da Farmácia e do Medicamento, Ministério da Saúde. 526 Farmacovigilância em Portugal. 2004, Lisboa: INFARMED-Instituto Nacional da Farmácia e do Medicamento, Ministério da Saúde. 526
9.
go back to reference Classen DC, Pestotnik SL, Evans RS, et al. Description of a computerized adverse drug event monitor using a hospital information system. Hosp Pharm 1992; 27(9): 774, 776–9, 783PubMed Classen DC, Pestotnik SL, Evans RS, et al. Description of a computerized adverse drug event monitor using a hospital information system. Hosp Pharm 1992; 27(9): 774, 776–9, 783PubMed
10.
go back to reference Classen DC, Pestotnik SL, Evans RS, et al. Computerized surveillance of adverse drug events in hospital patients. 1991. Qual Saf Health Care, 2005; 14(3): 221–5; discussion 225–6PubMedCrossRef Classen DC, Pestotnik SL, Evans RS, et al. Computerized surveillance of adverse drug events in hospital patients. 1991. Qual Saf Health Care, 2005; 14(3): 221–5; discussion 225–6PubMedCrossRef
11.
go back to reference Bates DW, Evans RS, Murff H, et al. Detecting adverse events using information technology. J Am Med Inform Assoc 2003; 10(2): 115–28PubMedCrossRef Bates DW, Evans RS, Murff H, et al. Detecting adverse events using information technology. J Am Med Inform Assoc 2003; 10(2): 115–28PubMedCrossRef
12.
go back to reference Polimeni G, Russo A, Catania MA, et al. Drug safety information through the internet: the experience of an Italian website. Drug Saf 2009; 32(3): 245–53PubMedCrossRef Polimeni G, Russo A, Catania MA, et al. Drug safety information through the internet: the experience of an Italian website. Drug Saf 2009; 32(3): 245–53PubMedCrossRef
13.
go back to reference Ortega A, Aquinagalde A, Lacasa C, et al. Efficacy of an adverse drug reaction electronic reporting system integrated into a hospital information system. Ann Pharmacother 2008; 42(10): 1491–6PubMedCrossRef Ortega A, Aquinagalde A, Lacasa C, et al. Efficacy of an adverse drug reaction electronic reporting system integrated into a hospital information system. Ann Pharmacother 2008; 42(10): 1491–6PubMedCrossRef
14.
go back to reference Ribeiro L, Cunha JP, Cruz-Correia RJ. Information systems heterogeneity and interoperability inside hospitals: a survey. In Health Inf 2010; Valencia: 337–43 Ribeiro L, Cunha JP, Cruz-Correia RJ. Information systems heterogeneity and interoperability inside hospitals: a survey. In Health Inf 2010; Valencia: 337–43
15.
go back to reference Figueiras A, Herdeiro MT, Polónia J, et al. An educational intervention to improve physician reporting of adverse drug reactions: a cluster-randomized controlled trial. JAMA 2011; 296(9): 1086–93CrossRef Figueiras A, Herdeiro MT, Polónia J, et al. An educational intervention to improve physician reporting of adverse drug reactions: a cluster-randomized controlled trial. JAMA 2011; 296(9): 1086–93CrossRef
16.
go back to reference Pedrós Vallano A, Cereza G, et al. An intervention to improve spontaneous adverse drug reaction reporting by hospital physicians: a time series analysis in Spain. Drug Saf 2009; 32(1): 77–83CrossRef Pedrós Vallano A, Cereza G, et al. An intervention to improve spontaneous adverse drug reaction reporting by hospital physicians: a time series analysis in Spain. Drug Saf 2009; 32(1): 77–83CrossRef
Metadata
Title
Promoting Spontaneous Adverse Drug Reaction Reporting in Hospitals Using a Hyperlink to the Online Reporting Form
An Ecological Study in Portugal
Authors
Dr Inês Ribeiro-Vaz
Cristina Santos
Altamiro da Costa-Pereira
Ricardo Cruz-Correia
Publication date
01-05-2012
Publisher
Springer International Publishing
Published in
Drug Safety / Issue 5/2012
Print ISSN: 0114-5916
Electronic ISSN: 1179-1942
DOI
https://doi.org/10.2165/11597190-000000000-00000

Other articles of this Issue 5/2012

Drug Safety 5/2012 Go to the issue